We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Poolbeg Pharma PLC on Wednesday announced its immunomodulator I patent has been granted in the US. The London-based ...
Poolbeg Pharma PLC 20 November 2024 Poolbeg Pharma plc - POLB 001 Patent Granted in United States Further strengthens Poolbeg's robust intellectual property portfolio 20 November...
Poolbeg Pharma PLC 06 November 2024 REACH Poolbeg Pharma plc to present POLB 001 pre-clinical study data at the...
Poolbeg Pharma PLC 18 September 2024 Poolbeg Pharma plc - Interim results for the six months to 30 June 2024 ...
Poolbeg Pharma PLC 27 August 2024 Poolbeg Pharma plc Poolbeg Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference 27 August 2024 - Poolbeg Pharma (AIM: POLB...
Poolbeg Pharma PLC 12 August 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not sepa ...
Poolbeg Pharma PLC 26 July 2024 Poolbeg Pharma plc Voluntary Delisting from OTCQB Market 26 July 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.35 | -4.34782608696 | 8.05 | 8.3 | 7.6 | 907375 | 7.99298451 | DE |
4 | -0.2 | -2.53164556962 | 7.9 | 9.1 | 7.6 | 900217 | 8.25089203 | DE |
12 | -4.45 | -36.6255144033 | 12.15 | 12.15 | 7.15 | 1130854 | 8.75872767 | DE |
26 | -4.6 | -37.3983739837 | 12.3 | 14.25 | 7.15 | 1274953 | 11.21467663 | DE |
52 | -1.85 | -19.3717277487 | 9.55 | 15.7 | 7.15 | 1584783 | 10.7629704 | DE |
156 | -2.55 | -24.8780487805 | 10.25 | 15.7 | 4.1 | 1324092 | 8.78321333 | DE |
260 | -3.3 | -30 | 11 | 15.7 | 4.1 | 1321271 | 8.99624684 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions